Good evening :)
$
₹
Fresenius Medical Care Corporation

Fresenius Medical Care Corporation

FMS

NYSE
Asset Logo

Fresenius Medical Care Corporation

FMS

NYSE
$23.186.69% (+1.45)
$
₹
$23.186.69% (+1.45)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max

Healthcare

Medical Care Facilities

Large Cap

With a market cap of $11.6B the stock is ranked 856

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

12.56
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

0.85
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$1.73
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

0.74
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

4.23%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

4.01%

Analyst Ratings & Forecast

Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 

Based on 7 analysts reports

Buy
1 analyst
Hold
3 analysts
Sell
3 analysts

Price Upside

+8.32%

Earnings Growth

-7.09%

Rev. Growth

-0.55%

See Detailed Forecast

Company Profile

Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Peers

Compare with peers Compare with peers 

Peers

Compare with peers Compare with peers 
CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.05
24.05
1Y Return
17.07%
17.07%
Buy Reco %
92.59
92.59
The Cigna Group
CI
The Cigna Group
P/E Ratio
12.21
12.21
1Y Return
11.63%
11.63%
Buy Reco %
70.83
70.83
Labcorp Holdings Inc.
LH
Labcorp Holdings Inc.
P/E Ratio
29.00
29.00
1Y Return
46.14%
46.14%
Buy Reco %
70.58
70.58
Quest Diagnostics Incorporated
DGX
Quest Diagnostics Incorporated
P/E Ratio
24.98
24.98
1Y Return
38.77%
38.77%
Buy Reco %
52.94
52.94
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
78.31%
78.31%
Buy Reco %
96.15
96.15
Compare with Peers

Forecast

Forecast

Price

Revenue

Earnings

Price Forecast

Price Forecast

Lower price growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The 12-month consensus target implies 8.32% growth, versus a trailing 3-year CAGR of 10.66%.

2026
Current$21.73Baseline
Analyst Target - 1 year
Target$23.54+8.32%

All values in $

202220232024202520262027$16.71$19.87$23.04Target+8.32%
2026
Current$21.73Baseline
Analyst Target - 1 year
Target$23.54+8.32%

All values in $

Revenue Forecast

Revenue Forecast

Lower revenue growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -0.55% growth, versus a trailing 3-year CAGR of 0.39%.

2025
Current$19.62Baseline
Forecast for Dec 2026
High$20.15+2.7%
Average$19.51-0.55%
Low$19.12-2.58%

All values in $ Billion

20212022202320242025202617.6119.3919.4519.3319.62Low-2.58%Average-0.55%High+2.7%
2025
Current$19.62Baseline
Forecast for Dec 2026
High$20.15+2.7%
Average$19.51-0.55%
Low$19.12-2.58%

All values in $ Billion

Earnings Per Share Forecast

Earnings Per Share Forecast

Lower earnings growth forecast versus trailing 3-year CAGR
Compares analyst forecast growth with historical annualized growth.

The next fiscal year's mean estimate implies -7.09% growth, versus a trailing 3-year CAGR of 22.14%.

2025
Current$2.15Baseline
Forecast for Dec 2026
High$2.05-4.51%
Average$2-7.09%
Low$1.94-9.67%

All values in $

2021202220232024202520261.671.181.281.532.15Low-9.67%Average-7.09%High-4.51%
2025
Current$2.15Baseline
Forecast for Dec 2026
High$2.05-4.51%
Average$2-7.09%
Low$1.94-9.67%

All values in $

Financials

Financials

Income

Balance Sheet

Cash Flow

4.8
0.2
5
0.3
4.6
0.1
4.8
0.2
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue4.724.764.765.084.884.794.885.064.614.86
Net Income0.070.180.210.060.150.220.270.320.110.21
Net Profit Margin1.50%3.92%4.47%1.31%3.09%4.70%5.62%6.45%2.54%4.49%
See CostsAll values in $ Billion

Peers

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Care Facilities

Valuation

Returns

Forecast

ScreenerCompare valuation on Screener
StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Fresenius Medical Care Corporation 12.560.850.74
CVS Health Corp24.051.420.20
The Cigna Group12.211.840.81
ScreenerCompare valuation on Screener

Price Comparison

Price Comparison

Compare FMS with any stock or ETF
Compare FMS with any stock or ETF
Comparing from
FMS
CVS
CI
Loading...

Frequently asked questions

  1. Fresenius Medical Care Corporation (FMS) share price today is $23.18 as of November 5, 2026 at 2:29 AM IST. The stock touched a day high of $23.23 and a day low of $22.62.

  2. Fresenius Medical Care Corporation stock trades on NYSE under the ticker symbol FMS.

  3. Fresenius Medical Care Corporation's market capitalization is $11.56B as of November 5, 2026 at 2:29 AM IST.

  4. Fresenius Medical Care Corporation's price-to-earnings (P/E) ratio is 12.56 as of November 5, 2026.

  5. Fresenius Medical Care Corporation's price-to-book (P/B) ratio is 0.85 as of November 5, 2026.

  6. Yes, Fresenius Medical Care Corporation pays a dividend, with a current dividend yield of 4.01%.

  7. Yes, You can buy Fresenius Medical Care Corporation shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Fresenius Medical Care Corporation shares in three steps: 1. Search Fresenius Medical Care Corporation on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Fresenius Medical Care Corporation trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Fresenius Medical Care Corporation (FMS) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4313 shares at the current price of $23.18.

Loading...